Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

Trial Profile

Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs Dexamethasone (Primary) ; Methotrexate (Primary) ; Ranibizumab (Primary)
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Acronyms MERIT
  • Most Recent Events

    • 25 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 13 Oct 2016 Planned initiation date changed from 1 Apr 2016 to 1 Nov 2016.
    • 10 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top